4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-25-000031
CEO bought 5,000 shares at $1.21 ($6,044)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vaddi Krishna CEO | 2024-12-31 | Purchase | +5,000 | $1.21 | $6,044 | 142,553 | I |
| Open-market purchases · 5,000 sh · avg $1.21 · $6,044 | |||||||
Loading xslF345X05/primarydocument.xml…